# T Stamp Inc: financial statements, quarterly

IDAI · Nasdaq · CIK 1718939 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/idai.md) · [Financials](/companies/idai/financials.md) · [Filings](/companies/idai/filings.md) · [Insiders](/companies/idai/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/idai/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [3,066](/filings/0001718939-24-000210.md) | [575 d](/filings/0001718939-25-000080.md) | [574](/filings/0001718939-25-000109.md) | [500](/filings/0001718939-25-000139.md) | [511](/filings/0001718939-25-000163.md) | [1,497 d](/filings/0001718939-26-000024.md) | [545](/filings/0001718939-26-000029.md) | [813](/filings/0001718939-26-000053.md) | [872](/filings/0001718939-25-000163.md) | [909 d](/filings/0001718939-26-000024.md) | [757](/filings/0001718939-26-000029.md) | [900](/filings/0001718939-26-000053.md) |
| Research and development | $k | [605](/filings/0001718939-24-000210.md) | [539 d](/filings/0001718939-25-000080.md) | [452](/filings/0001718939-25-000109.md) | [565](/filings/0001718939-25-000139.md) | [570](/filings/0001718939-25-000163.md) | [554 d](/filings/0001718939-26-000024.md) | [437](/filings/0001718939-26-000029.md) | [513](/filings/0001718939-26-000053.md) | [575](/filings/0001718939-25-000163.md) | [647 d](/filings/0001718939-26-000024.md) | [598](/filings/0001718939-26-000029.md) | [757](/filings/0001718939-26-000053.md) |
| Selling, general and administrative | $k | [2,054](/filings/0001718939-24-000210.md) | [2,495 d](/filings/0001718939-25-000080.md) | [2,492](/filings/0001718939-25-000109.md) | [2,132](/filings/0001718939-25-000139.md) | [2,182](/filings/0001718939-25-000163.md) | [1,707 d](/filings/0001718939-26-000024.md) | [1,788](/filings/0001718939-26-000029.md) | [1,431](/filings/0001718939-26-000053.md) | [1,509](/filings/0001718939-25-000163.md) | [1,747 d](/filings/0001718939-26-000024.md) | [1,855](/filings/0001718939-26-000029.md) | [1,904](/filings/0001718939-26-000053.md) |
| Operating income | $k | [(21.9)](/filings/0001718939-24-000210.md) | [(2,906) d](/filings/0001718939-25-000080.md) | [(2,849)](/filings/0001718939-25-000109.md) | [(2,625)](/filings/0001718939-25-000139.md) | [(2,677)](/filings/0001718939-25-000163.md) | [(1,216) d](/filings/0001718939-26-000024.md) | [(2,163)](/filings/0001718939-26-000029.md) | [(1,683)](/filings/0001718939-26-000053.md) | [(1,771)](/filings/0001718939-25-000163.md) | [(2,044) d](/filings/0001718939-26-000024.md) | [(2,269)](/filings/0001718939-26-000029.md) | [(2,397)](/filings/0001718939-26-000053.md) |
| Income tax | $k | [0.0](/filings/0001718939-23-000026.md) | [(13.5) d](/filings/0001718939-25-000080.md) | [0.0](/filings/0001718939-24-000085.md) | [0.0](/filings/0001718939-25-000139.md) | [0.0](/filings/0001718939-25-000163.md) | [7.8 d](/filings/0001718939-26-000024.md) | [0.0](/filings/0001718939-26-000029.md) | [0.0](/filings/0001718939-26-000053.md) | [0.0](/filings/0001718939-25-000163.md) | [13.8 d](/filings/0001718939-26-000024.md) | [0.0](/filings/0001718939-26-000029.md) | [(4.4)](/filings/0001718939-26-000053.md) |
| Net income | $k | [(35.2)](/filings/0001718939-24-000210.md) | [(2,885) d](/filings/0001718939-25-000080.md) | [(2,679)](/filings/0001718939-25-000109.md) | [(2,598)](/filings/0001718939-25-000139.md) | [(1,256)](/filings/0001718939-25-000163.md) | [(6,012) d](/filings/0001718939-26-000024.md) | [(2,157)](/filings/0001718939-26-000029.md) | [(1,712)](/filings/0001718939-26-000053.md) | [(1,912)](/filings/0001718939-25-000163.md) | [(8,330)](/filings/0001718939-26-000024.md) | [(2,231)](/filings/0001718939-26-000029.md) | [(2,694)](/filings/0001718939-26-000053.md) |
| Diluted EPS | $ per share | [0.00](/filings/0001718939-24-000210.md) | not reported | [(3.97)](/filings/0001718939-25-000109.md) | [(3.19)](/filings/0001718939-25-000139.md) | [(1.06)](/filings/0001718939-25-000163.md) | not reported | [(0.89)](/filings/0001718939-26-000029.md) | [(0.69)](/filings/0001718939-26-000053.md) | [(0.72)](/filings/0001718939-25-000163.md) | not reported | [(0.42)](/filings/0001718939-26-000029.md) | [(0.48)](/filings/0001718939-26-000053.md) |
| Basic EPS | $ per share | [0.00](/filings/0001718939-24-000210.md) | not reported | [(3.97)](/filings/0001718939-25-000109.md) | [(3.19)](/filings/0001718939-25-000139.md) | [(1.06)](/filings/0001718939-25-000163.md) | not reported | [(0.89)](/filings/0001718939-26-000029.md) | [(0.69)](/filings/0001718939-26-000053.md) | [(0.72)](/filings/0001718939-25-000163.md) | not reported | [(0.42)](/filings/0001718939-26-000029.md) | [(0.48)](/filings/0001718939-26-000053.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [3.2](/filings/0001718939-23-000026.md) | [3.1](/filings/0001718939-25-000080.md) | [0.8](/filings/0001718939-24-000085.md) | [0.7](/filings/0001718939-24-000135.md) | [0.6](/filings/0001718939-24-000210.md) | [2.8](/filings/0001718939-26-000024.md) | [1.1](/filings/0001718939-25-000109.md) | [0.3](/filings/0001718939-25-000139.md) | [5.4](/filings/0001718939-25-000163.md) | [6.0](/filings/0001718939-26-000053.md) | [3.9](/filings/0001718939-26-000029.md) | [6.3](/filings/0001718939-26-000053.md) |
| Current assets | $m | [4.3](/filings/0001718939-23-000026.md) | [4.7](/filings/0001718939-25-000080.md) | [2.4](/filings/0001718939-24-000085.md) | [1.9](/filings/0001718939-24-000135.md) | [2.2](/filings/0001718939-24-000210.md) | [4.7](/filings/0001718939-26-000024.md) | [2.5](/filings/0001718939-25-000109.md) | [1.5](/filings/0001718939-25-000139.md) | [7.1](/filings/0001718939-25-000163.md) | [7.5](/filings/0001718939-26-000053.md) | [5.3](/filings/0001718939-26-000029.md) | [8.1](/filings/0001718939-26-000053.md) |
| Total assets | $m | [7.5](/filings/0001718939-23-000026.md) | [7.9](/filings/0001718939-25-000080.md) | [5.6](/filings/0001718939-24-000085.md) | [5.2](/filings/0001718939-24-000135.md) | [10.6](/filings/0001718939-24-000210.md) | [8.6](/filings/0001718939-26-000024.md) | [6.6](/filings/0001718939-25-000109.md) | [5.7](/filings/0001718939-25-000139.md) | [11.2](/filings/0001718939-25-000163.md) | [11.2](/filings/0001718939-26-000053.md) | [9.7](/filings/0001718939-26-000029.md) | [12.5](/filings/0001718939-26-000053.md) |
| Current liabilities | $m | [2.0](/filings/0001718939-23-000026.md) | [2.7](/filings/0001718939-25-000080.md) | [2.8](/filings/0001718939-24-000085.md) | [3.0](/filings/0001718939-24-000135.md) | [3.7](/filings/0001718939-24-000210.md) | [4.2](/filings/0001718939-26-000024.md) | [1.1](/filings/0001718939-25-000109.md) | [1.7](/filings/0001718939-25-000139.md) | [3.6](/filings/0001718939-25-000163.md) | [1.0](/filings/0001718939-26-000053.md) | [1.0](/filings/0001718939-26-000029.md) | [1.3](/filings/0001718939-26-000053.md) |
| Total liabilities | $m | [3.2](/filings/0001718939-23-000026.md) | [4.0](/filings/0001718939-25-000080.md) | [4.1](/filings/0001718939-24-000085.md) | [4.3](/filings/0001718939-24-000135.md) | [5.0](/filings/0001718939-24-000210.md) | [5.4](/filings/0001718939-26-000024.md) | [2.4](/filings/0001718939-25-000109.md) | [3.1](/filings/0001718939-25-000139.md) | [5.0](/filings/0001718939-25-000163.md) | [2.4](/filings/0001718939-26-000053.md) | [2.4](/filings/0001718939-26-000029.md) | [7.7](/filings/0001718939-26-000053.md) |
| Long-term debt | $m | [0.9](/filings/0001718939-23-000026.md) | [1.0](/filings/0001718939-25-000080.md) | [0.9](/filings/0001718939-24-000085.md) | [1.0](/filings/0001718939-24-000135.md) | [1.0](/filings/0001718939-24-000210.md) | [1.0](/filings/0001718939-26-000024.md) | [1.0](/filings/0001718939-25-000109.md) | [1.1](/filings/0001718939-25-000139.md) | [1.1](/filings/0001718939-25-000163.md) | [1.1](/filings/0001718939-26-000053.md) | [1.1](/filings/0001718939-26-000029.md) | [1.1](/filings/0001718939-26-000053.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [3.1](/filings/0001718939-26-000024.md) | not reported | not reported | [2.1](/filings/0001718939-25-000163.md) | [0.0](/filings/0001718939-26-000024.md) | not reported | not reported |
| Shareholders' equity | $m | [4.1](/filings/0001718939-23-000026.md) | [3.8](/filings/0001718939-25-000080.md) | [1.4](/filings/0001718939-24-000085.md) | [0.8](/filings/0001718939-24-000135.md) | [5.4](/filings/0001718939-24-000210.md) | [3.0](/filings/0001718939-26-000024.md) | [4.1](/filings/0001718939-25-000109.md) | [2.4](/filings/0001718939-25-000139.md) | [6.1](/filings/0001718939-25-000163.md) | [8.7](/filings/0001718939-26-000053.md) | [7.2](/filings/0001718939-26-000029.md) | [4.6](/filings/0001718939-26-000053.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: not reported
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $k | [(2,303) d](/filings/0001718939-24-000210.md) | [(1,968) d](/filings/0001718939-25-000080.md) | [(2,158)](/filings/0001718939-25-000109.md) | [(1,599) d](/filings/0001718939-25-000139.md) | [(2,426) d](/filings/0001718939-25-000163.md) | [(2,736) d](/filings/0001718939-26-000024.md) | [(1,540)](/filings/0001718939-26-000029.md) | [(2,100)](/filings/0001718939-25-000139.md) | [(4,010)](/filings/0001718939-25-000163.md) | [(1,670) d](/filings/0001718939-26-000024.md) | [(1,858)](/filings/0001718939-26-000029.md) | [(2,228) d](/filings/0001718939-26-000053.md) |
| Capital expenditure | $k | [0.5 d](/filings/0001718939-24-000210.md) | [4.2 d](/filings/0001718939-25-000080.md) | [2.8](/filings/0001718939-25-000109.md) | [6.3 d](/filings/0001718939-25-000139.md) | [3.5 d](/filings/0001718939-25-000163.md) | [2.0 d](/filings/0001718939-26-000024.md) | [36.9](/filings/0001718939-26-000029.md) | [1.9 d](/filings/0001718939-26-000053.md) | [(0.0) d](/filings/0001718939-25-000163.md) | [7.2 d](/filings/0001718939-26-000024.md) | [22.8](/filings/0001718939-26-000029.md) | [11.5 d](/filings/0001718939-26-000053.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | thousands of shares | [4,693](/filings/0001718939-23-000026.md) | [5,045](/filings/0001718939-24-000085.md) | [6,757](/filings/0001718939-24-000135.md) | [8,156](/filings/0001718939-24-000210.md) | [674](/filings/0001718939-25-000109.md) | [815](/filings/0001718939-25-000139.md) | [1,181](/filings/0001718939-25-000163.md) | [2,436](/filings/0001718939-26-000029.md) | [2,497](/filings/0001718939-26-000053.md) | [2,659](/filings/0001718939-25-000163.md) | [5,282](/filings/0001718939-26-000029.md) | [5,615](/filings/0001718939-26-000053.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 5,639,291 at 2026-08-12, from the cover of the [10-Q filed 2026-08-13](/filings/0001718939-26-000053.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:46 ET. No prices; not investment advice.